Saccharide digestion inhibiting composition
CA 1255591 A · Owner: Takeda Pharmaceutical Company Limited · Inventors: Matsuo, Takao; Kitamori, Nobuyuki; Horii, Satoshi
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention concerns a saccharide digestion inhibitor comprising a combination of an .alpha.-glucosidase inhibitor and non-pathogenic lactic acid producing live bacteria and a saccharide digestion inhibiting composition containing both of said components. Oral administration of the saccharide digestion inhibitor or composition to man or animals results in the prevention or treatment of diabetes and obesity without resort to dieting and substantially without inducing side effects such as diarrhea, abdominal distension etc. which are, found with the .alpha.-glucosidase inhibiting substance administered alone.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Granted June 13, 1989. A Canadian patent filed before October 1, 1989 lasted 17 years from grant, so its term ended June 13, 2006.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.